Fatty Acid Synthesis Inhibitors

All categories
DBCAT001001Pharmacologic class

Compounds that interfere with FATTY ACID SYNTHASE resulting in a reduction of FATTY ACIDS. This is a target mechanism in humans of some ANTINEOPLASTIC AGENTS and ANTI-OBESITY AGENTS and of some ANTI-INFECTIVE AGENTS which interfere... A DrugBank category of 5 drugs. 3 of them are approved.

Drugs

What you can answer from here — as of August 24, 2016

5DrugsEach linked to its full drug card
Listed above
18Drug targetsEvery drug–target pair in the class, with bond type
Sign in
2,461Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
12Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Fatty Acid Synthesis Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In